| Item Type | Name |
|
Concept
|
Adolescent
|
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid, Accelerated Phase
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Graft vs Leukemia Effect
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Young Adult
|
|
Academic Article
|
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.
|
|
Academic Article
|
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.
|
|
Academic Article
|
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
|
|
Academic Article
|
Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantation.
|
|
Academic Article
|
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
|
|
Academic Article
|
Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations.
|
|
Academic Article
|
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
|
|
Academic Article
|
Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange.
|
|
Academic Article
|
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
|
|
Academic Article
|
Principles and overview of allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
|
|
Academic Article
|
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.
|
|
Academic Article
|
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
|
|
Academic Article
|
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
|
|
Academic Article
|
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.
|
|
Academic Article
|
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
|
|
Academic Article
|
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies.
|
|
Academic Article
|
Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
|
|
Academic Article
|
A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.
|
|
Academic Article
|
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.
|
|
Academic Article
|
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
|
|
Academic Article
|
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation.
|
|
Academic Article
|
Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
|
|
Academic Article
|
Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.
|
|
Academic Article
|
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
|
|
Academic Article
|
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.
|
|
Academic Article
|
Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis.
|
|
Academic Article
|
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion.
|
|
Academic Article
|
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.
|
|
Academic Article
|
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
|
|
Academic Article
|
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
|
|
Academic Article
|
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.
|
|
Academic Article
|
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
|
|
Academic Article
|
Allogeneic bone marrow transplantation for low-grade lymphoma.
|
|
Academic Article
|
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
|
|
Academic Article
|
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
Development of severe sclerotic chronic GVHD during treatment with dasatinib.
|
|
Academic Article
|
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
|
|
Academic Article
|
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
|
|
Academic Article
|
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.
|
|
Academic Article
|
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
|
|
Academic Article
|
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
|
|
Academic Article
|
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.
|
|
Academic Article
|
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
|
|
Academic Article
|
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
|
|
Academic Article
|
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
|
|
Academic Article
|
Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.
|
|
Academic Article
|
The risk of secondary leukemias following autologous stem cell transplantation.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
|
|
Academic Article
|
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
|
|
Academic Article
|
Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature.
|